Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Howell

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Fluency Disorders|February 19, 2018
Use of a phoneme monitoring task to examine lexical access in adults who do and do not stutterTimothy A Howell, Nan Bernstein Ratner
Pharmacoeconomics - Open|January 23, 2026
Content Validity of Two Generic Preference-Based Measures in Retinitis Pigmentosa, Including X-Linked Retinitis PigmentosaLouis S Matza, Timothy A Howell, Qiaoyi Zhang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 13, 2022
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIVLouis S Matza, Timothy A Howell, Vasiliki Chounta, et al.
Journal of Medical Economics|June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 23, 2021
A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and OpportunitiesBrooke M Currie, Timothy A Howell, Louis S Matza, et al.
Pharmacoeconomics - Open|February 7, 2022
Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell LymphomaTimothy A Howell, Louis S Matza, Monika P Jun, et al.
Obesity Science & Practice|August 7, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility modelsTimothy A Howell, Louis S Matza, Usha G Mallya, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 1, 2022
Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare DiseaseLindsey T Murray, Timothy A Howell, Louis S Matza, et al.
Journal of the Neurological Sciences|February 3, 2024
Qualitative interviews to support development of a patient-reported companion measure to the Glucocorticoid Toxicity IndexTimothy A Howell, Louis S Matza, John H Stone, et al.
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Fluency Disorders|February 19, 2018
Use of a phoneme monitoring task to examine lexical access in adults who do and do not stutterTimothy A Howell, Nan Bernstein Ratner
Pharmacoeconomics - Open|January 23, 2026
Content Validity of Two Generic Preference-Based Measures in Retinitis Pigmentosa, Including X-Linked Retinitis PigmentosaLouis S Matza, Timothy A Howell, Qiaoyi Zhang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 13, 2022
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIVLouis S Matza, Timothy A Howell, Vasiliki Chounta, et al.
Journal of Medical Economics|June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 23, 2021
A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and OpportunitiesBrooke M Currie, Timothy A Howell, Louis S Matza, et al.
Pharmacoeconomics - Open|February 7, 2022
Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell LymphomaTimothy A Howell, Louis S Matza, Monika P Jun, et al.
Obesity Science & Practice|August 7, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility modelsTimothy A Howell, Louis S Matza, Usha G Mallya, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 1, 2022
Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare DiseaseLindsey T Murray, Timothy A Howell, Louis S Matza, et al.
Journal of the Neurological Sciences|February 3, 2024
Qualitative interviews to support development of a patient-reported companion measure to the Glucocorticoid Toxicity IndexTimothy A Howell, Louis S Matza, John H Stone, et al.
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Pageof 2